Li, M., He, H., Ruan, Z., Zhu, Y., Li, R., He, X., . . . Yang, Z. (2017). Central nervous system progression in advanced non–small cell lung cancer patients with EGFR mutations in response to first-line treatment with two EGFR-TKIs, gefitinib and erlotinib: A comparative study. BMC Cancer.
Styl ChicagoLi, Meng-Xia, et al. "Central Nervous System Progression in Advanced Non–small Cell Lung Cancer Patients With EGFR Mutations in Response to First-line Treatment With Two EGFR-TKIs, Gefitinib and Erlotinib: A Comparative Study." BMC Cancer 2017.
Citace podle MLALi, Meng-Xia, et al. "Central Nervous System Progression in Advanced Non–small Cell Lung Cancer Patients With EGFR Mutations in Response to First-line Treatment With Two EGFR-TKIs, Gefitinib and Erlotinib: A Comparative Study." BMC Cancer 2017.